Virtus Investment Advisers’s Zymeworks ZYME Stock Holding History

Virtus Investment Advisers’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$268K	Buy	10,702 +261	+2%	+$6.17K	0.07%	298
2025 Q4	$275K	Buy	10,441 +1,755	+20%	+$38.3K	0.07%	280
2025 Q3	$148K	Buy	8,686 +1,508	+21%	+$21.6K	0.04%	376
2025 Q2	$90.1K	Sell	7,178 -5,828	-45%	-$69.4K	0.03%	377
2025 Q1	$155K	Buy	+13,006	New	+$177K	0.04%	321
2024 Q4	–	Sell	-9,819	Closed	-$123K	–	412
2024 Q3	$123K	Sell	9,819 -7,181	-42%	-$78.2K	0.1%	237
2024 Q2	$145K	Sell	17,000 -39,363	-70%	-$350K	0.12%	211
2024 Q1	$593K	Hold	56,363	–	–	0.42%	66
2023 Q4	$586K	Buy	+56,363	New	+$449K	0.44%	61

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Virtus Investment Advisers's ZYME Position: Q1 2026 in Review

Virtus Investment Advisers increased its Zymeworks (ZYME) stake by 2.5% in Q1 2026, buying an estimated $6.17K and bringing the position to 10,702 shares worth $268K. The position accounts for 0.07% of the portfolio, ranked #298.

Virtus Investment Advisers first reported a position in ZYME in Q4 2023 and has held it in 9 quarters since. The position peaked at $593K in Q1 2024. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

Virtus Investment Advisers held 10,702 shares of Zymeworks worth $268K as of Q1 2026.
Virtus Investment Advisers bought 261 Zymeworks shares in Q1 2026, an estimated $6.17K.
Zymeworks made up 0.07% of Virtus Investment Advisers's portfolio in Q1 2026, its #298 holding.
Virtus Investment Advisers first reported a position in Zymeworks in Q4 2023 and has held it in 9 quarters since.
Virtus Investment Advisers's Zymeworks position peaked at $593K in Q1 2024.
211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Virtus Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.